Cranbury, NJ — PM360, the premier information resource for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device sectors, has named Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN, Program Director, Academy of Oncology Nurse & Patient Navigators (AONN+), as one of the 2021 PM360 ELITE 100 in the Master Educators category. Now in its seventh year, the PM360 ELITE (Exceptional • Leaders • Innovators • Transformers • Entrepreneurs) represent the most influential people in the healthcare industry today.
Sharon serves as Program Director of AONN+, which includes more than 9000 nurse and patient navigators. In this role, she has been instrumental in the growth of more than 30 (and counting) Navigator Networks throughout the country. These networks provide support and educational resources to navigators locally and regionally. Sharon has also started a scholarship fund to help AONN+ members to attend the Midyear and Annual conferences.
“Sharon’s passion to advance the role of navigation is always based in seeking research, evidence, and best practice,” said Emily Gentry, Senior Director of Education and Program Development, AONN+. “Sharon is a role model, mentor, and an aspiration to oncology navigators.”
Sharon has been a voice of the AONN+ Leadership Council since its 2009 inception. From 2012 to 2019, she co-chaired the semiannual AONN+ conferences and actively served on the teams for certification, metrics, and acuity. She has written articles in peer-reviewed journals and patient advocacy magazines, authored book chapters, and travels nationally lecturing on navigation significance. Her work as Program Director continues to create opportunities for education, knowledge, and life-sustaining support—at exactly the time it is needed the most.
The PM360 ELITE Awards were established in 2015 to recognize individuals who have made a significant impact on the healthcare industry throughout their careers. More than 500 submissions were received and nominees were evaluated and selected by the PM360 editorial staff based on their accomplishments; testimonials from their bosses, clients, and colleagues; and supporting evidence that reflects the impact of their efforts. A total of 100 winners were selected across 19 categories, including Creative Directors, COVID Heroes, Data Miners, Digital Crusaders, Disrupters, Drug Researchers and Developers, Entrepreneurs, Launch Experts, Leaders of the Future, Marketing Teams, Master Educators, Mentors, Patient Advocates, PR Gurus, Sales MVPs, Strategists, Talent Acquisition Leaders, Tech-know Geeks, and Transformational Leaders.
“As the pandemic surged across the globe in 2020, all eyes were on the healthcare and life sciences industries in search for answers, treatments, vaccines, and hope—and the very best in our industry were able to deliver all of that,” says Anna Stashower, CEO and Publisher of PM360. “While every year our ELITE winners demonstrate the power of the life sciences to impact lives, this year’s winners had to do so by overcoming unprecedented challenges in record times. Their incredible work helped to navigate HCPs, patients, and doctors through this pandemic and get us to where we are now as restrictions are slowly being lifted and we start to return to more of the things we love.”
The winners were profiled in PM360’s May 2021 issue. You can read their profiles online at https://www.pm360online.com/the-2021-pm360-elite-100.
Additionally, the 2021 ELITE 100 will be celebrated during a virtual event on June 22 at 7:00 PM ET. A special keynote address from Uber ELITE Winner Stéphane Bancel, CEO, Moderna, will kick off the celebration.
Tickets for the event can be purchased at https://www.pm360online.com/elitetickets2021.
PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment.
The journal’s targeted and insightful editorial focuses on issues that directly impact critical decision-making, including planning and implementation of cutting-edge strategies, trends, the latest technological advances, branding/marketing, advertising/ promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the “360” in the title signifies the span of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read.
By providing the full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.
About Amplity Health
Amplity Health proudly serves as co-founder and association management company of the Academy of Oncology Nurse & Patient Navigators (AONN+) and the Association for Value-Based Cancer Care (AVBCC).
The true partner of global healthcare companies, Amplity Health continually challenges the boundaries of medical and commercial strategies to accelerate the approval and launch of new drugs to improve the lives of patients. We are proud of our inclusive culture and our EPIIC values. Amplity has the expertise, global infrastructure, and data-driven insights to help clients overcome their medical and commercial challenges.
Amplity’s wide-ranging capabilities include clinical and medical outsourced teams; clinical and medical capability development; companion diagnostic and precision medicine solutions; medical communications; expert engagement; remote and field solutions for patients, payers, and physicians; and strategic and access consulting. Amplity’s one-of-a-kind Insights database offers clients a detailed view into patient–provider interactions and provider treatment rationale not found through any other provider.
Amplity Health is a portfolio company of Altamont Capital Partners.
About the Academy of Oncology Nurse & Patient Navigators, Inc
The Academy of Oncology Nurse & Patient Navigators, Inc (AONN+), is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. The organization, which has nearly 8900 members, was founded in 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services in order to better manage the complexities of the cancer treatment process.
About the Journal of Oncology Navigation & Survivorship
The Journal of Oncology Navigation & Survivorship® (www.jons-online.com) is the official publication of AONN+. JONS seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
About CONQUER: the patient voice magazine
CONQUER: the patient voice magazine (www.conquer-magazine.com) is the AONN+ premier forum for patients with cancer. CONQUER features articles written by and for patients with cancer, survivors, nurse navigators, and other oncology team members. This magazine addresses the issues that patients, their family members, and caregivers face every day in an easy-to-read format. Issues include interviews with patients with cancer, information on access to care, and articles on lifestyle topics such as nutrition, stress management, personal finance, and legal and employer issues. CONQUER also features patient stories that are nominated for the AONN+ Hero of Hope™ award, which is presented at the AONN+ Annual Conference. All stories are compiled in a special issue of CONQUER at the end of the year.
Gwen Coverdale, 267-884-6328